PUBLISHER: TechNavio | PRODUCT CODE: 1559437
PUBLISHER: TechNavio | PRODUCT CODE: 1559437
The human immunoglobulin market is forecasted to grow by USD 9696 mn during 2023-2028, accelerating at a CAGR of 10.11% during the forecast period. The report on the human immunoglobulin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in plasma donation, rising prevalence of immunodeficiency disorders, and growing geriatric population.
Technavio's human immunoglobulin market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 8.65% |
CAGR | 10.11% |
Incremental Value | $9696 mn |
By Application
By End-user
By Geographical Landscape
This study identifies the rising research and development in human immunoglobulin as one of the prime reasons driving the human immunoglobulin market growth during the next few years. Also, growing regulatory approvals on human immunoglobulin and advancements in manufacturing technologies in production of human immunoglobulin will lead to sizable demand in the market.
The report on the human immunoglobulin market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human immunoglobulin market vendors that include ADMA Biologics Inc., argenx SE, Baxter International Inc., Bio Products Laboratory Ltd., CSL Ltd., Emergent BioSolutions Inc., Grifols SA, Hualan Biological Vaccine Inc., Kamada Ltd., Kedrion Spa, LFB SA, Octapharma AG, Pfizer Inc., Prothya Biosolutions Netherlands BV, Sanquin, Shanghai RAAS Blood Products Co. Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd, and Takeda Pharmaceutical Co. Ltd.. Also, the human immunoglobulin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: